Milestones

Home About Us

Milestones

1988

By exploring Weigao Group’s history, one can witness the continuity and legancy of its culture and spirit.

2025

Down

2023
2021
2018
2017
2015
2010
2006
2004
2002
2000
1998
1993
1991
1988

Weigao Group held the second strategic seminar, putting forward the development strategy of "three transformations"

The construction of Weigao (Shanghai) International Research Institute was officially initiated, and Shandong Weigao Orthopaedic Device Co., Ltd. (WEGO ORTHO) went public on the SSE STAR Market.

Weigao Group won the "Nomination Award of China Quality Award" for the first time and obtained the approval for the establishment of a National Technical Standard Innovation Base of Medical Device.

Weigao Group acquired Argon Medical Devices Holdings, Inc. (the United States) at USD 850 million, introducing internationally advanced technology to expand our global footprints.

Weigao Group was ranked among the "Top 500 Chinese Enterprises" for the first time, becoming the only medical device company on the list.

Weigao Group started all-around cooperation with the Chinese Academy of Sciences.

The Technology Center of Weigao Group was authenticated as a national enterprise technology center by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs, and the State Taxation Administration.

Shandong Weigao Group Medical Polymer Co., Ltd. went public on the Stock Exchange of Hong Kong.

Weigao Group held a meeting at Changdao County, Yantai, Shandong Province, putting forward the development strategy of "one center and three adjustments".

Weigao Group obtained approval from the Ministry of Science and Technology for the construction of the "863" Industrialization Base, starting to build a medical polymer material industrial park.

The company was restructured and Weihai Medical Polymer Co., Ltd. was founded.

The company passed the Decision on Transforming Operation Mechanism, selling its products to more than 10 countries and regions including Russia, the Middle East, Australia, Indonesia, Thailand, and South Africa, with sales revenue exceeding RMB 100 million.

The company built a national standardized production workshop for disposable infusion sets, promoting the formulation of enterprise standards and the standardized production of medical polymer instruments nationwide.

The Company was founded in pursuit of goodness and charity, developing the policy of "pioneering, innovative, and pragmatic".

2023

Weigao Group held the second strategic seminar, putting forward the development strategy of "three transformations"

2021

The construction of Weigao (Shanghai) International Research Institute was officially initiated, and Shandong Weigao Orthopaedic Device Co., Ltd. (WEGO ORTHO) went public on the SSE STAR Market.

2018

Weigao Group won the "Nomination Award of China Quality Award" for the first time and obtained the approval for the establishment of a National Technical Standard Innovation Base of Medical Device.

2017

Weigao Group acquired Argon Medical Devices Holdings, Inc. (the United States) at USD 850 million, introducing internationally advanced technology to expand our global footprints.

2015

Weigao Group was ranked among the "Top 500 Chinese Enterprises" for the first time, becoming the only medical device company on the list.

2010

Weigao Group started all-around cooperation with the Chinese Academy of Sciences.

2006

2004

Shandong Weigao Group Medical Polymer Co., Ltd. went public on the Stock Exchange of Hong Kong.

2002

Weigao Group held a meeting at Changdao County, Yantai, Shandong Province, putting forward the development strategy of "one center and three adjustments".

2000

Weigao Group obtained approval from the Ministry of Science and Technology for the construction of the "863" Industrialization Base, starting to build a medical polymer material industrial park.

1998

The company was restructured and Weihai Medical Polymer Co., Ltd. was founded.

1993

1991

1988

The Company was founded in pursuit of goodness and charity, developing the policy of "pioneering, innovative, and pragmatic".